0 CHECKOUT

PRODUCT FILTERS

REGION

39
12
6
6
1

COUNTRY

12
1

CATEGORIES

  • 98
  • 33
  • 26
  • 18
  • 13
  • 8
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

47
94
137
198

PUBLISHED

6
20
72
198

PRODUCT TYPE

74
74
24
22
2
2

Search for: "Disease and Therapy Review: Multiple Sclerosis"

Multiple Sclerosis - Pipeline Review, H1 2015

Multiple Sclerosis - Pipeline Review, H1 2015 Summary the, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015 Summary The report ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights

Summary Secondary Progressive Multiple Sclerosis (SPMS)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Secondary Progressive Multiple Sclerosis (SPMS). The main...

Published:  February 2016
Price:  From

Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights

Summary Primary Progressive Multiple Sclerosis (PPMS)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Primary Progressive Multiple Sclerosis (PPMS). The main objective...

Published:  February 2016
Price:  From

Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights

Summary Relapsing Remitting Multiple Sclerosis (RRMS)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Relapsing Remitting Multiple Sclerosis (RRMS). The main objective...

Published:  February 2016
Price:  From

Relapsing Multiple Sclerosis (RMS)-Pipeline Insights

Summary Relapsing Multiple Sclerosis (RMS)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Relapsing Multiple Sclerosis (RMS). The main objective of this report...

Published:  February 2016
Price:  From

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015 Summary The report ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015’, provides an overview of the Relapsing Multiple Sclerosis...

Published:  November 2015
Price:  From

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015 Summary The report ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015’, provides an overview of the...

Published:  September 2015
Price:  From

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015 Summary This, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015’, provides an overview of the Primary...

Published:  March 2015
Price:  From

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency...

Published:  July 2013
Price:  From

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015 Summary This, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing...

Published:  May 2015
Price:  From

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015 Summary The report ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015’, provides an overview of the...

Published:  November 2015
Price:  From

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015 Summary This, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015’, provides an overview of the Secondary...

Published:  January 2015
Price:  From

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015 Summary The report ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015’, provides an overview of...

Published:  July 2015
Price:  From

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015 Summary This, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing Multiple Sclerosis...

Published:  April 2015
Price:  From

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Multiple Sclerosis Therapeutics...

Published:  February 2012
Price:  From

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update Summary Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized...

Published:  April 2013
Price:  From

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

Published:  January 2016
Price:  From

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015 Summary The report ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

Published:  September 2015
Price:  From

Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tysabri (Multiple Sclerosis) - Forecast and Market...

Published:  March 2013
Price:  From
Loading Indicator

Our Clients

  • Hewlett-Packard Company
  • Microsoft Corporation
  • Philips N.V.
  • SONY Corporation
  • Cypress Semiconductor Corporation
  • Panasonic Corporation